// App-Quantinova.ai

4392 : Comparison of the Use of TFPI Inhibition and Plasma Dilution to Increase the Sensitivity of Thrombin Generation Assay to Measure the Procoagulant Activity of Microvesicles

Researchers

Presenter

  • Francois Mullier

Principal Investigators

  • Bernard Chatelain

  • Jean-Michel Dogne

  • Christian Chatelain

Medical Centers

  • Hematology laboratory, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences NARILIS, Yvoir, Belgium

  • CHU UCL de Mont-Godinne, Yvoir, Belgium

  • Hematology laboratory, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences NARILIS, Yvoir, Belgium

  • Department of Pharmacy Namur Thrombosis and Hemostasis Center NTHC-Narilis, Namur, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Coagulation Factor III, Tissue Factor

  • Tissue factor pathway inhibitor

Drug/Treatment

  • Evithrom

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim